|
bdnf |
6 |
|
chemical constituent |
6 |
|
cytotoxic activity |
6 |
|
depression |
6 |
|
erk1/2 |
6 |
|
gleditsia sinensis |
6 |
|
leguminosae |
6 |
|
structural identification |
6 |
|
celastrol |
5 |
|
animals |
4 |
|
antidepressive agents |
4 |
|
behavior, animal |
4 |
|
brain |
4 |
|
cytokines |
4 |
|
neuritogenesis |
4 |
|
neuroprotection |
4 |
|
20(s)-protopanaxadiol |
3 |
|
adipose tissue |
3 |
|
amygdalin |
3 |
|
arginase-2 |
3 |
|
calreticulin |
3 |
|
cytotoxicity |
3 |
|
dopamine |
3 |
|
flavonoids |
3 |
|
inflammation |
3 |
|
liver |
3 |
|
lps |
3 |
|
macrophage polarization |
3 |
|
mtor |
3 |
|
nanomedicine drug delivery |
3 |
|
nanomicelles |
3 |
|
neurodegenerative diseases |
3 |
|
neuroprotective |
3 |
|
neurorestorative |
3 |
|
nitric oxide |
3 |
|
nrf2/heme oxygenase-1 |
3 |
|
obesity |
3 |
|
p70s6k |
3 |
|
pain |
3 |
|
parkinson's disease |
3 |
|
parkinson’s disease |
3 |
|
peg-pcl nanomicelles |
3 |
|
pharmacological |
3 |
|
pi3k/akt |
3 |
|
proteomics |
3 |
|
puerarin |
3 |
|
raga |
3 |
|
reactive oxygen species |
3 |
|
reduced glutathione |
3 |
|
spared nerve injury |
3 |
|
4-vinylpyridine |
2 |
|
apoptosis |
2 |
|
blood-brain barrier |
2 |
|
bornyl caffeate |
2 |
|
chronic diseases |
2 |
|
gsh depletion |
2 |
|
human breast cancer mcf-7 cells |
2 |
|
isoflavones |
2 |
|
mechanism |
2 |
|
mitochondrial dysfunction |
2 |
|
molecular imprinting |
2 |
|
n-propargyl caffeamide (paca) |
2 |
|
n-propargyl caffeate amide (paca) |
2 |
|
nanoparticle |
2 |
|
network pharmacology |
2 |
|
neuritogenic |
2 |
|
neuroprotective agents |
2 |
|
neurotrophic functions |
2 |
|
ngf/trka pathway |
2 |
|
nrf2/ho-1 |
2 |
|
oxygen glucose deprivation |
2 |
|
piceid |
2 |
|
ros |
2 |
|
signal transduction |
2 |
|
solid phase extraction |
2 |
|
stilbenoid glycoside |
2 |
|
structure-activity relationship |
2 |
|
tight junction proteins |
2 |
|
tyrosinase inhibition |
2 |
|
epilepsy |
1 |
|
gut microbiome |
1 |
|
immune regulation, disease |
1 |
|
medicinal and food homologous |
1 |
|
natural products |
1 |
|
neurological diseases |
1 |
|
stroke |
1 |
|
therapeutic targets |
1 |
